Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

А New Combination of Prognostic Markers in Follicular Lymphoma That Influences the Choice of Therapy

Ekaterina S. Nesterova, Nataliya A. Severina, Bella V. Biderman, Andrey B. Sudarikov, Tatiana N. Obukhova, Alla M. Kovrigina, Sergey K. Kravchenko, Eduard G. Gemdzhian, Valery G. Savchenko

Blood (2021) 138 (Supplement 1): 4520.

https://doi.org/10.1182/blood-2021-145104

Published: 2021

Journal Articles

Genetic Lesions in Russian CLL Patients with the Most Common Stereotyped Antigen Receptors

Bella V. Biderman, PhD, Nataliya Severina, PhD, Ekaterina B Likold, Tatiana N. Obukhova, MD PhD, Andrey B. Sudarikov, PhD DSc, V. G. Savchenko, MD PhD Academician

Blood (2020) 136 (Supplement 1): 16–17.

https://doi.org/10.1182/blood-2020-140663

Published: 2020

Journal Articles

Interim Results of Russian Acute Lymphoblastic Leukemia (RALL-2016) Study with Centralized MRD-Monitoring and Randomization for Autologous HSCT with Non-Myeloablative Conditioning in Adult Ph-Negative ALL Patients

Blood (2019) 134 (Supplement_1): 5072.

https://doi.org/10.1182/blood-2019-124701

Published: 2019

Journal Articles

The MRD-Negativity Rate Measured By Flow Cytometry after the 1 st and the 2 nd Induction Course Among CR AML Patients from Different Cytogenetic Subgroups Does Not Differ Though the Morphological CR Achievement Does

Elena Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Irina V. Galtseva, PhD, Tatiana I. Lobanova, MD, Yuliya O. Davydova, Nikolay M. Kapranov, Andrey N. Sokolov, MD, Alina V. Kokhno, MD, PhD, Roman V. Tivikov, MD, Irina A. Lukyanova, MD, Tatiana N. Obukhova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 1495.

https://doi.org/10.1182/blood-2018-99-116581

Published: 2018

Journal Articles

MRD Status Did Not Correspond to the Relapse Incidence within One Year of Follow-up By Non-Intensive but Non-Interruptive Approach: The First Interim Results of the Russian Prospective Multicenter RALL-2016 Trial for Ph-Negative Adult ALL

Blood (2018) 132 (Supplement 1): 5185.

https://doi.org/10.1182/blood-2018-99-116318

Published: 2018

Journal Articles

The Effectiveness of Eltrombopag at the Different Stages of Aplastic Anemia and Probability of Clonal Expansion

Anton V. Luchkin, MD, Elena A. Mikhaylova, MD PhDProf, Zalina T. Fidarova, MD PhD, Anastasia V. Abramova, MD, Vera V. Troitskaya, MD PhD, Tatiana I. Lobanova, MD, Alina E. Krasilnikova, Resident Physician, Irina V. Galtseva, PhD, Yuliya O. Davydova, Nikolay M. Kapranov, Tatiana N. Obukhova, MD PhD, Lubov Grebenyuk, MD, Murat Vagida, MD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 5108.

https://doi.org/10.1182/blood-2018-99-118738

Published: 2018

Journal Articles

Persistence of the Minimal Residual Disease at the End of Induction Is Not a Factor of Poor Prognosis If Imatinib Was Changed to the Dasatinib By Ph+ RALL Protocol in Ph-Positive Acute Lymphoblastic Leukemia Patients

Olga A. Gavrilina, MDPhD, Elena N. Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Larisa A. Kuzmina, MD PhD, Sergey N. Bondarenko, PhDMD, Valery Lapin, Tatiana N. Obukhova, MD PhD, Andrey Sudarikov, PhD, Valery G. Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 2714.

https://doi.org/10.1182/blood.V130.Suppl_1.2714.2714

Published: 2017

Journal Articles

Two Variants of Follicular Lymphoma Grade 3

Lyubov V. Plastinina, Alla M. Kovrigina, MD PhD, Sergey K. Kravchenko, MD PhD, Tatiana N. Obukhova, MD PhD, Ekaterina S. Nesterova, MD PhD, Aminat U. Magomedova, MD PhD, Yana K. Mangasarova, MD PhD, Anna E. Misyurina, PhD MD, Fatima Babayeva, Sergei M. Kulikov, PhD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 5161.

https://doi.org/10.1182/blood.V130.Suppl_1.5161.5161

Published: 2017

Journal Articles

Theraputic Approaches to High Grade B-Cell Lymphoma Double-Hit and Follicular Lymphoma with C -MYC , BCL2 and/or BCL6 rearrangements. Single Center Expirience

Anna E. Misyurina, PhD MD, Sergey K. Kravchenko, MD PhD, Alla M. Kovrigina, MD PhD, Elena A. Baryakh, MD PhD, Lubov V. Plastinina, MD PhD, Aminat U. Magomedova, MD PhD, Tatiana N. Obukhova, MD PhD, Ekaterina S. Nesterova, MD PhD, Vsevolod A. Misyurin, PhD, Andrey V. Misyurin, PhD, Andrey I. Vorobiev, Fatima E. Babaeva, Valery Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 5236.

https://doi.org/10.1182/blood.V130.Suppl_1.5236.5236

Published: 2017

Journal Articles

Blinatumomab + Tyrosine Kinase Inhibitors in the Treatment of Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Patients - Clinical Efficacy and Peripheral Blood Lymphocytes Subpopulations Kinetics

Andrey N. Sokolov, MD PhD, Elena N. Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Irina V. Galtseva, MD PhD, Julia O. Davidova, Nikolai M. Kapranov, Tatiana N. Obukhova, PhD, Valeri G. Savchenko, MD PhD Prof.

Blood (2016) 128 (22): 4024.

https://doi.org/10.1182/blood.V128.22.4024.4024

Published: 2016

Journal Articles

Treatment of Primary Aggressive Gastrointestinal Lymphomas with Intensive Chemotherapy: A 14-Year Experience

Eugene E. Zvonkov, MD PhD, Nelly G. Gabeeva, PhD, Anna K. Morozova, Olga A. Gavrilina, MD PhD, Anna A. Sidorova, MD, Daria A. Koroleva, MD, Tatiana N. Obukhova, PhD, Alla Kovrigina, MD PhD, Elena N. Parovichnikova, MD PhD, Valery G Savchenko, MD PhD academician

Blood (2016) 128 (22): 5388.

https://doi.org/10.1182/blood.V128.22.5388.5388

Published: 2016

Journal Articles

Long-Term Efficacy of the Combined Immunosuppressive Therapy (IST): Cyclosporine with/without Splenectomy - in Patients with Different Forms of Myelodysplastic Syndromes

Valeri G Savchenko, MD, PhD, Alina Kokhno, MD, PhD, Elena N. Parovichnikova, MD PhD, Elena Mikhailova, MD, PhD, Vera V. Troitskaya, MD PhD, Larisa A. Kuzmina, MD PhD, Mikhail Drokov, MDPhD, Valentina N. Dvirnyk, MD, PhD, Alla M. Kovrigina, MD PhD Prof., Tatiana N. Obukhova, PhD

Blood (2015) 126 (23): 5238.

https://doi.org/10.1182/blood.V126.23.5238.5238

Published: 2015

Journal Articles

Late Clonal Disorders in Patients with Aplastic Anemia

Alina Kokhno, MD, PhD, Elena A Mikhaylova, MD PhD Prof, Zalina T. Fidarova, Elena Ustinova, MD PhD, Vera V. Troitskaya, MD PhD, Andrey N. Sokolov, MD PhD, Larisa P. Mendeleeva, MD PhD, Larisa A. Kuzmina, MD PhD, Nina V. Tsvetaeva, MD PhD, Valentina N. Dvirnyk, MD, PhD, Tatiana N. Obukhova, PhD, Alla M. Kovrigina, MD PhD Prof., Elena N. Parovichnikova, MD PhD, Valeri Savchenko, MD PhD Prof.

Blood (2015) 126 (23): 4787.

https://doi.org/10.1182/blood.V126.23.4787.4787

Published: 2015

Journal Articles

Absence of High-Dose Consolidation Courses and Low Numbers of Allogeneic HSCTs Did Not Affect Overall Optimistic Results in B-Cell Precursor Ph-Negative Adult ALL Patients Treated By Non-Intensive but Non-Interruptive ALL-2009 Protocol: Data of the Russian ALL Study Group

Blood (2015) 126 (23): 2497.

https://doi.org/10.1182/blood.V126.23.2497.2497

Published: 2015

Journal Articles

Less Toxic Gemcitabine-Oxaliplatin Based Induction Regimen (R-GIDIOX) Prior to Autologous SCT Produces Outcomes Similar to High-Dose Cytarabine Containing Intensive Induction Regimen in Mantle Cell Lymphoma – a Follow up Report of the Multicenter Study

Vladimir I. Vorobyev, MD PhD, Sergei K. Kravchenko, MD PhD, Eduard G. Gemdzhian, PhD, Jana K. Mangasarova, MD PhD, Elena Baryakh, MDPhD, Alla M. Kovrigina, MD PhD Prof., Tatiana N. Obukhova, PhD, Kamil Kaplanov, Egor I. Dubrovin, MD, Ivan A Vorobjev, Prof., Natalya G. Turina, MD PhD, Valeri G. Savchenko, MD Prof.

Blood (2014) 124 (21): 1726.

https://doi.org/10.1182/blood.V124.21.1726.1726

Published: 2014

Journal Articles

B-Cell Lymphoma Unclassified, Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma: A Single Center Experience of Intensive Chemotherapy with and without Auto-SCT

Anna E. Lukina, MD PhD, Elena A. Baryakh, MD PhD, Alla M. Kovrigina, MD PhD Prof., Eduard G. Gemdzhian, PhD, Vsevolod A. Misyurin, PhD, Sergey K. Kravchenko, MD PhD, Vladimir I. Vorobyev, MD PhD, Jana K. Mangasarova, MD PhD, Aminat U. Magomedova, MD PhD, Yuri U. Polyakov, PhD, Tatiana N. Obukhova, PhD, Eugene E. Zvonkov, MD PhD, Anna K. Morozova, MD PhD, Valeri G. Savchenko, MD PhD Prof.

Blood (2014) 124 (21): 5902.

https://doi.org/10.1182/blood.V124.21.5902.5902

Published: 2014

NARROW

А New Combination of Prognostic Markers in Follicular Lymphoma That Influences the Choice of Therapy

Genetic Lesions in Russian CLL Patients with the Most Common Stereotyped Antigen Receptors

Interim Results of Russian Acute Lymphoblastic Leukemia (RALL-2016) Study with Centralized MRD-Monitoring and Randomization for Autologous HSCT with Non-Myeloablative Conditioning in Adult Ph-Negative ALL Patients

The MRD-Negativity Rate Measured By Flow Cytometry after the 1 st and the 2 nd Induction Course Among CR AML Patients from Different Cytogenetic Subgroups Does Not Differ Though the Morphological CR Achievement Does

MRD Status Did Not Correspond to the Relapse Incidence within One Year of Follow-up By Non-Intensive but Non-Interruptive Approach: The First Interim Results of the Russian Prospective Multicenter RALL-2016 Trial for Ph-Negative Adult ALL

The Effectiveness of Eltrombopag at the Different Stages of Aplastic Anemia and Probability of Clonal Expansion

Persistence of the Minimal Residual Disease at the End of Induction Is Not a Factor of Poor Prognosis If Imatinib Was Changed to the Dasatinib By Ph+ RALL Protocol in Ph-Positive Acute Lymphoblastic Leukemia Patients

Two Variants of Follicular Lymphoma Grade 3

Theraputic Approaches to High Grade B-Cell Lymphoma Double-Hit and Follicular Lymphoma with C -MYC , BCL2 and/or BCL6 rearrangements. Single Center Expirience

Blinatumomab + Tyrosine Kinase Inhibitors in the Treatment of Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Patients - Clinical Efficacy and Peripheral Blood Lymphocytes Subpopulations Kinetics

Treatment of Primary Aggressive Gastrointestinal Lymphomas with Intensive Chemotherapy: A 14-Year Experience

Long-Term Efficacy of the Combined Immunosuppressive Therapy (IST): Cyclosporine with/without Splenectomy - in Patients with Different Forms of Myelodysplastic Syndromes

Late Clonal Disorders in Patients with Aplastic Anemia

Absence of High-Dose Consolidation Courses and Low Numbers of Allogeneic HSCTs Did Not Affect Overall Optimistic Results in B-Cell Precursor Ph-Negative Adult ALL Patients Treated By Non-Intensive but Non-Interruptive ALL-2009 Protocol: Data of the Russian ALL Study Group

Less Toxic Gemcitabine-Oxaliplatin Based Induction Regimen (R-GIDIOX) Prior to Autologous SCT Produces Outcomes Similar to High-Dose Cytarabine Containing Intensive Induction Regimen in Mantle Cell Lymphoma – a Follow up Report of the Multicenter Study

B-Cell Lymphoma Unclassified, Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma: A Single Center Experience of Intensive Chemotherapy with and without Auto-SCT

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only